All articles tagged with #aoms
A study reviewing 11 research papers found that weight loss achieved through anti-obesity medications like Ozempic often reverses within weeks after stopping the drugs, with an average regain of 2.5 kg over 20 weeks, highlighting challenges in maintaining weight loss post-treatment.
This systematic review and meta-analysis examines the long-term effects of anti-obesity medications (AOMs) on body weight after discontinuation, finding significant weight regain starting around 8 weeks post-discontinuation that persists up to 20 weeks, with variations based on medication type and patient characteristics.
The article highlights the undervalued role of first-generation anti-obesity medications, such as Orlistat and phentermine, which are cost-effective, accessible, and suitable for certain patient groups, especially those seeking moderate weight loss or with specific comorbidities. Despite the popularity of newer GLP-1 agonists, these older medications remain important options in obesity treatment, with considerations for safety, tolerability, and individual patient needs.